This map shows the geographic impact of Das Un's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Das Un with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Das Un more than expected).
This network shows the impact of papers produced by Das Un. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Das Un. The network helps show where Das Un may publish in the future.
Co-authorship network of co-authors of Das Un
This figure shows the co-authorship network connecting the top 25 collaborators of Das Un.
A scholar is included among the top collaborators of Das Un based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Das Un. Das Un is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Un, Das. (2009). Albumin and lipid enriched albumin for the critically ill.. PubMed. 57. 53–9.12 indexed citations
3.
Un, Das. (2006). Hypertension as a low-grade systemic inflammatory condition that has its origins in the perinatal period.. PubMed. 54. 133–42.26 indexed citations
4.
Un, Das. (2006). Aberrant expression of perilipins and 11-beta-HSD-1 as molecular signatures of metabolic syndrome X in south east Asians.. PubMed. 54. 637–49.8 indexed citations
5.
Un, Das. (2003). Metabolic syndrome X is common in Indians: but, why and how?. PubMed. 51. 987–98.8 indexed citations
6.
Un, Das, et al.. (2001). Effect of melatonin on two stage skin carcinogenesis in Swiss mice.. PubMed. 6(3). 471–5.24 indexed citations
7.
Un, Das, et al.. (2001). Lipid peroxides, anti-oxidants and nitric oxide in patients with pre-eclampsia and essential hypertension.. PubMed. 6(5). 901–7.71 indexed citations
8.
Un, Das. (1999). Essential fatty acids in health and disease.. PubMed. 47(9). 906–11.32 indexed citations
9.
Un, Das. (1999). GLUT-4, tumour necrosis factor, essential fatty acids and daf-genes and their role in glucose homeostasis, insulin resistance, non-insulin dependent diabetes mellitus, and longevity.. PubMed. 47(4). 431–5.16 indexed citations
10.
Un, Das. (1992). Nutrients, essential fatty acids and prostaglandins interact to augment immune responses and prevent genetic damage and cancer.. PubMed. 5(2). 106–10.27 indexed citations
11.
Un, Das. (1991). Tumour necrosis factor/cachectin: biology and relevance to disease.. PubMed. 39(2). 201–4.4 indexed citations
12.
Un, Das. (1990). Tuning free radical metabolism to kill tumor cells selectively with emphasis on the interaction(s) between essential fatty acids, free radicals, lymphokines and prostaglandins.. PubMed. 33(1). 94–111.8 indexed citations
13.
Un, Das. (1990). Free radicals: biology and relevance to disease.. PubMed. 38(7). 495–8.12 indexed citations
14.
Un, Das, et al.. (1987). Essential fatty acids and cancer with particular reference to Hodgkin's disease.. PubMed. 35(2). 137–8.5 indexed citations
15.
Ells, G., et al.. (1986). Selected fatty acids as possible intermediates for selective cytotoxic activity of anticancer agents involving oxygen radicals.. PubMed. 6(2). 291–5.22 indexed citations
16.
Un, Das. (1982). Atherosclerosis and prostaglandins.. PubMed. 4(2). 127–32.10 indexed citations
17.
Un, Das. (1980). Cardiac arrhythmias, anti-arrhythmic drugs and prostaglandins.. PubMed. 74(1). 23–4.2 indexed citations
18.
Un, Das, et al.. (1980). Verapamil as a prostaglandin antagonist.. PubMed. 18(8). 917–8.2 indexed citations
19.
Un, Das. (1979). Fever, leukocytes and prostaglandins.. PubMed. 27(7). 659–61.3 indexed citations
20.
Un, Das, et al.. (1978). Prostaglandin E. Levels in human bronchial asthma.. PubMed. 26(9). 767–9.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.